Ghent University Academic Bibliography

Your filters: cql: keyword exact "Triple-negative breast cancer"

Add to list
- Conference Paper
- C3
Transcriptomic adaptation of the cold versus hot triple-negative breast tumor immune microenvironment to PD-L1 blockade

Robbe Salembier (UGent) , Caro De Haes (UGent) , Bo Wylin (UGent) , Kristel Demeyere (UGent) , Steven Van Laere, Nicolaas Van Renne (UGent) , Christos Sotiriou, Evelyne Meyer (UGent) and Jonas Steenbrugge (UGent)

(2025) Immune Niches in Cancer & Inflammation Conference 2025, Abstracts.
Add to list
- Journal Article
- A1
- open access
Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

Robbe Salembier (UGent) , Caro De Haes (UGent) , Julie Bellemans (UGent) , Kristel Demeyere (UGent) , Wim Van Den Broeck (UGent) , Niek Sanders (UGent) , Steven Van Laere, Traci R. Lyons, Evelyne Meyer (UGent) and Jonas Steenbrugge (UGent)

(2024) BREAST CANCER RESEARCH. 26(1).
Add to list
- Journal Article
- A1
- open access
Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer : proof-of-principle

Jonas Steenbrugge (UGent) , Glenn Pauwelyn, Kristel Demeyere (UGent) , Nausikaa Devriendt (UGent) , Hilde De Rooster (UGent) , Niek Sanders (UGent) , Jan H. Spaas and Evelyne Meyer (UGent)

(2023) FRONTIERS IN IMMUNOLOGY. 14.
Add to list
- Journal Article
- A1
- open access
One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Julie Bellemans (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Timothy Perera, Olivier De Wever (UGent) , Wim Van Den Broeck (UGent) , Ward De Spiegelaere (UGent) , Niek Sanders (UGent) , et al.

(2022) ONCOIMMUNOLOGY. 11(1).
Add to list
- Conference Paper
- C3
Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Abstracts.
Add to list
- Conference Paper
- C3
Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) OncoDot.3 symposium, Abstracts.
Add to list
- Conference Paper
- C3
Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Josephine De Vliegher, Annegret Van der Aa, Eric Ciamporcero, Timothy Perera and Evelyne Meyer (UGent)

(2021) OncoDot.3 symposium, Abstracts.
Add to list
- Journal Article
- A1
- open access
Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Niels Vander Elst (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Luc Dirix, Steven Van Laere and Evelyne Meyer (UGent)

(2019) FRONTIERS IN IMMUNOLOGY. 10.
Add to list
- Journal Article
- A1
- open access
Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Koen Breyne (UGent) , Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Niek Sanders (UGent) , Wim Van Den Broeck (UGent) , Cecile Colpaert, Peter Vermeulen, Steven Van Laere and Evelyne Meyer (UGent)

(2018) JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 37.
Add to list
Comparison of the adipose and luminal mammary gland compartment as orthotopic inoculation sites in a 4T1-based immunocompetent preclinical model for triple-negative breast cancer

Jonas Steenbrugge (UGent) , Koen Breyne (UGent) , Sofie Denies (UGent) , Melissa Dekimpe, Kristel Demeyere (UGent) , Olivier De Wever (UGent) , Peter Vermeulen, Steven Van Laere, Niek Sanders (UGent) and Evelyne Meyer (UGent)

(2016) JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA. 21(3-4). p.113-122

Academic Bibliography

Transcriptomic adaptation of the cold versus hot triple-negative breast tumor immune microenvironment to PD-L1 blockade

Chitin-mediated blockade of chitinase-like proteins reduces tumor immunosuppression, inhibits lymphatic metastasis and enhances anti-PD-1 efficacy in complementary TNBC models

Xenogeneic equine stem cells activate anti-tumor adaptive immunity in a 4T1-based intraductal mouse model for triple-negative breast cancer : proof-of-principle

One cisplatin dose provides durable stimulation of anti-tumor immunity and alleviates anti-PD-1 resistance in an intraductal model for triple-negative breast cancer

Immunomodulation by cisplatin chemotherapy in an immunocompetent intraductal model for triple-negative breast cancer

Unexpected effects of a selective and potent c-MET inhibitor in an immunocompetent intraductal model for triple-negative breast cancer

Splenic immunomodulatory effects of cisplatin in an immunocompetent intraductal model for triple-negative breast cancer

Comparative profiling of metastatic 4T1- vs. non-metastatic Py230-based mammary tumors in an intraductal model for triple-negative breast cancer

Anti-inflammatory signaling by mammary tumor cells mediates prometastatic macrophage polarization in an innovative intraductal mouse model for triple-negative breast cancer

Comparison of the adipose and luminal mammary gland compartment as orthotopic inoculation sites in a 4T1-based immunocompetent preclinical model for triple-negative breast cancer

Contents

Support

Contact